CE vs MEOH vs MOS Stock Comparison

Celanese, Methanex and Mosaic Prices as of Oct 28, 2026 Peers: Industry group
1 more company in this comparison (OLN) Create a free account to keep reading and compare up to 10 companies.
CE Celanese Corp
$48.83 +6.4% 1M +18.5% 1Y
Market cap
$5.36B
P/E
–
Revenue (TTM)
$9.71B
Div. yield
0.25%
Commodity Chemicals Basic Materials
MEOH Methanex Corp
$63.55 +6.3% 1M +84.1% 1Y
Market cap
$4.91B
P/E
57.5x
Revenue (TTM)
$4.27B
Div. yield
1.14%
Commodity Chemicals Basic Materials
8 wins
MOS Mosaic Co
$18.31 -17.7% 1M -37.7% 1Y
Market cap
$5.82B
P/E
–
Revenue (TTM)
$12.25B
Div. yield
4.81%
Fertilizers Basic Materials
3 wins

Head to Head

11 decided of 12

Methanex leads on 8 of the 12 questions below (Methanex 8, Mosaic 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCEMEOHMOSLeader
Larger companyMarket capitalisation $5.36B $4.91B $5.82B MOS
Cheaper on earningsLower P/E, profitable companies only -4.6x 57.5x -9.1x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 7.7x 5.9x 53.9x MEOH
Faster revenue growthRevenue growth, trailing twelve months -2.2% +19.2% +8.8% MEOH
More profitableNet margin, trailing twelve months -12.0% 1.9% -5.2% MEOH
Better return on capitalReturn on invested capital -4.1% 12.4% -1.0% MEOH
Less leveragedLower net debt / EBITDA 63.7x 1.8x 5.6x MEOH
Higher dividend yieldTrailing dividend yield 0.25% 1.14% 4.81% MOS
Better 1-year returnPrice return, last 12 months +18.5% +84.1% -37.7% MEOH
Better 5-year returnAnnualised price return, 5 years -21.3%/yr +7.3%/yr -15.1%/yr MEOH
Less volatileAnnualised volatility, 1 year 51.3% 50.4% 45.1% MOS
Higher overall scoreMean of the five percentile scores vs peers 30/100 76/100 42/100 MEOH

Percentile Scorecard

CEMEOHMOS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCEMEOHMOS
Valuation 59 #39 of 94 89 #11 of 94 54 #44 of 94
Growth 23 #70 of 91 62 #35 of 91 7 #85 of 91
Profitability 34 #56 of 84 93 #7 of 84 36 #54 of 84
Financial Health 13 #82 of 94 68 #31 of 94 31 #65 of 94
Shareholder Returns 22 #54 of 69 66 #24 of 69 82 #13 of 69
Overall 30 76 42
  • CE ranked among 99 companies in Chemicals
  • MEOH ranked among 99 companies in Chemicals
  • MOS ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCEMEOHMOSSPY
1 month +6.4%+6.3%-17.7% +0.9%
3 months +11.1%+16.3%-19.1% +5.9%
6 months -25.0%+0.4%-20.5% +8.5%
Year to date +15.5%+60.0%-24.0% +13.3%
1 year +18.5%+84.1%-37.7% +12.4%
3 years -57.0%+53.7%-44.7% +88.1%
3 years, per year -24.5%+15.4%-17.9% +23.5%
5 years -69.8%+41.9%-56.0% +68.2%
5 years, per year -21.3%+7.3%-15.1% +11.0%
10 years -32.5%+71.5%-23.0% +263.4%
10 years, per year -3.9%+5.5%-2.6% +13.8%

Risk

MeasureCEMEOHMOSSPY
Volatility, 1Y 51.3%50.4%45.1% 12.7%
Downside volatility, 1Y 46.5%48.8%44.2% 12.7%
Beta vs S&P 500, 1Y 0.41-0.310.62 1.00
Return / volatility, 1Y 0.361.67-0.84 0.98
Max drawdown, 5Y -79.6%-54.2%-77.9% -25.4%
From 52-week high -29.5%-3.3%-41.6% -0.9%
52-week high $69.24$65.72$31.36 $779.14
52-week low $35.53$33.88$17.26 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCEMEOHMOS
P/E now vs peer median -4.6xmedian 22.0x 57.5xmedian 22.0x -9.1xmedian 22.0x
P/S now vs peer median 0.6xmedian 1.4x 1.2xmedian 1.4x 0.5xmedian 1.4x
EV/EBITDA now vs peer median 95.8xmedian 12.4x 6.1xmedian 12.4x 11.4xmedian 12.4x
P/FCF now vs peer median 7.6xmedian 15.5x 4.0xmedian 15.5x -6.1xmedian 15.5x
P/B now vs peer median 1.2xmedian 1.7x 1.7xmedian 1.7x 0.5xmedian 1.7x
PEG now vs peer median 0.11median 1.84 -1.94median 1.84 0.28median 1.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCEMEOHMOS
Revenue $9.71B $4.27B $12.25B
Gross profit $2.03B – $1.35B
Operating income -$692.00M $655.47M -$169.80M
Net income -$1.16B $176.40M -$624.70M
Free cash flow $708.00M $1.22B -$947.10M
R&D $120.00M – –
EPS (diluted) $-10.60 $1.10 $-2.01
Cash & equivalents $1.36B $382.91M $294.00M
Total debt $12.01B $2.39B $21.00B
Shares (diluted) 110.25M 72.61M 317.90M
Enterprise value -$44.96M $3.63B $4.99B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCEMEOHMOS
P/E -4.6x 57.5x -9.1x
P/FCF 7.6x 4.0x -6.1x
P/Operating cash flow 5.4x 4.0x 13.1x
P/S 0.6x 1.2x 0.5x
P/B 1.2x 1.7x 0.5x
P/Tangible book 3.5x 1.7x 0.5x
EV/EBITDA 95.8x 6.1x 11.4x
EV/EBIT -23.1x 10.6x -67.0x
EV/Revenue 1.6x 1.6x 0.9x
EV/FCF 22.6x 5.7x -12.0x
EV/Operating cash flow 16.3x 5.7x 25.6x
PEG (3Y EPS CAGR) 0.11 -1.94 0.28

Growth

14 metrics
MetricCEMEOHMOS
Revenue growth (1Y) -2.2% 19.2% 8.8%
Revenue CAGR (3Y) -1.9% 2.4% -10.0%
Gross profit growth (1Y) -5.7% – -22.0%
Gross profit CAGR (3Y) -3.3% – -28.7%
Operating income growth (1Y) 11.1% 18.4% -121.3%
Operating income CAGR (3Y) -39.7% 13.7% -27.3%
Net income growth (1Y) 29.1% -47.3% -164.7%
Net income CAGR (3Y) -42.8% -21.7% -31.6%
EPS growth (1Y) 29.0% -70.4% -168.2%
EPS CAGR (3Y) -42.8% -29.6% -32.2%
Operating cash flow growth (1Y) -3.5% 21.9% -62.5%
Operating cash flow CAGR (3Y) -16.2% 14.5% -47.5%
Free cash flow growth (1Y) 12.0% 21.9% -22,126%
Free cash flow CAGR (3Y) -13.2% 14.5% -36.5%

Profitability

14 metrics
MetricCEMEOHMOS
Gross margin 20.9% – 11.0%
EBITDA margin 1.7% 26.6% 8.1%
Operating margin -7.1% 15.4% -1.4%
Pretax margin -11.6% 22.1% -2.0%
Net margin -12.0% 1.9% -5.2%
FCF margin 7.3% 28.5% -7.7%
Operating cash flow margin 10.1% 28.5% 3.6%
Return on equity -25.4% 6.3% -5.2%
Return on assets -5.3% – -2.5%
Return on invested capital -4.1% 12.4% -1.0%
Return on capital employed -3.9% – -0.8%
Asset turnover 0.5x – 0.5x
Cash conversion (OCF / net income) -0.8x 6.9x -0.7x
Stock comp / revenue 0.3% 1.4% 0.3%

Financial Health

11 metrics
MetricCEMEOHMOS
Debt / assets 56.1% – 23.8%
Debt / equity 2.6x 0.8x 0.5x
Net debt / EBITDA 63.7x 1.8x 5.6x
Debt / FCF 17.0x 2.0x -6.2x
Liabilities / assets 78.6% – 52.8%
Equity / assets 21.4% – 47.2%
Interest coverage -1.0x 2.9x –
Current ratio 1.4x – 1.3x
Quick ratio 0.8x – 0.3x
Cash ratio 0.3x – 0.1x
Altman Z-score 1.29 – 1.58

Shareholder Returns

7 metrics
MetricCEMEOHMOS
Dividend yield 0.2% 1.1% 4.8%
Net buyback yield – 3.5% –
Shareholder yield 0.2% 4.6% 4.8%
Payout ratio (earnings) -1.1% – -44.8%
Payout ratio (FCF) 1.8% – -29.6%
Dividend growth (1Y) -91.8% – 2.1%
Dividend CAGR (3Y) -65.0% – -4.7%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCEMEOHMOS
Forward P/E 7.7xFY2026 5.9xFY2026 53.9xFY2026
EPS, next fiscal year $6.33FY2026 $10.73FY2026 $0.34FY2026
EPS growth, next FY +59.0%FY2026 +433.8%FY2026 -85.0%FY2026
EPS growth, the year after -0.2% -43.2% +297.1%
Revenue, next fiscal year $9.75BFY2026 $5.37BFY2026 $11.74BFY2026
Revenue growth, next FY +2.2%FY2026 +50.9%FY2026 -2.6%FY2026
Revenue growth, the year after +7.8% -26.6% +15.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCEMEOHMOS
Held by institutions 100.0% 81.3% 95.2%
Institutions holding 458 212 662
Change in shares held, QoQ +10.8% +8.4% +7.4%
Institutions buying 246 132 374
Institutions selling 138 57 212
Buyers to sellers 1.78 2.32 1.76

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CEMEOHMOS
CE 1.00 0.47 0.41
MEOH 0.47 1.00 0.23
MOS 0.41 0.23 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CE, MEOH and MOS?

Mosaic (MOS) is the largest by market capitalisation: Celanese (CE) $5.36B, Methanex (MEOH) $4.91B, Mosaic (MOS) $5.82B.

Which company is growing faster?

Methanex (MEOH) grew revenue fastest over the trailing twelve months: Celanese (CE) -2.2%, Methanex (MEOH) +19.2%, Mosaic (MOS) +8.8%.

Which company is more profitable?

Methanex (MEOH) has the highest net margin (Celanese (CE) -12.0%, Methanex (MEOH) 1.9%, Mosaic (MOS) -5.2%). On return on invested capital, Methanex (MEOH) leads (Celanese (CE) -4.1%, Methanex (MEOH) 12.4%, Mosaic (MOS) -1.0%).

Which stock has performed better?

Over the past year Methanex (MEOH) returned the most: Celanese (CE) +18.5%, Methanex (MEOH) +84.1%, Mosaic (MOS) -37.7%. Over five years, Methanex (MEOH) compounded fastest (Celanese (CE) -21.3%/yr, Methanex (MEOH) +7.3%/yr, Mosaic (MOS) -15.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Mosaic (MOS) has the highest dividend yield: Celanese (CE) 0.25%, Methanex (MEOH) 1.14%, Mosaic (MOS) 4.81%.

Which stock is riskier?

By one-year price volatility, Mosaic (MOS) has been the steadiest (Celanese (CE) 51.3%, Methanex (MEOH) 50.4%, Mosaic (MOS) 45.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CE, MEOH and MOS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Methanex (MEOH) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.